Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET-Adjusted IMRT for NSCLC Trial (PAINT)

NCT02073968 is registered in ClinicalTrials.gov with Albert Einstein College of Medicine as lead sponsor.

NCT NCT02073968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02073968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET-Adjusted IMRT for NSCLC Trial (PAINT)
Lead sponsor
Albert Einstein College of Medicine
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2013
Completion date
November 30, 2020
Enrollment
35 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant neoplasm in the brain, recurrent non-small cell lung carcinoma, stage iia non-small cell lung carcinoma, stage iib non-small cell lung carcinoma, stage iiia non-small cell lung cancer, stage iiib non-small cell lung cancer, stage iv non-small cell lung cancer